Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on November 2, 2005
Journal of the American Society of Nephrology
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2005010112
This Article
Right arrow Full Text (Rapid PDF)
Right arrow Erratum (v17,p591)
Right arrow All Versions of this Article:
ASN.2005010112v1
16/12/3736    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gilbertson, D. T.
Right arrow Articles by Collins, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilbertson, D. T.
Right arrow Articles by Collins, A. J.

Received January 27, 2005
Accepted on September 20, 2005

CLINICAL SCIENCE: Epidemiology and Outcomes

Projecting the Number of Patients with End-Stage Renal Disease in the United States to the Year 2015

David T. Gilbertson *1, Jiannong Liu *, Jay L. Xue *{dagger}, Thomas A. Louis *{ddagger}, Craig A. Solid *, James P. Ebben *, and Allan J. Collins *{dagger}

*United States Renal Data System Coordinating Center and {dagger}University of Minnesota, Minneapolis, Minnesota; and {ddagger}Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland


1 To whom correspondence should be addressed. E-mail: dgilbertson{at}usrds.org.


  Abstract

The size of the prevalent ESRD population in the United States increased dramatically during the 1990s, from 196,000 in 1991 to 382,000 in 2000. Incidence also increased considerably during the same period, from 53,000 to 93,000 per year. If previous trends in ESRD incidence and prevalence continue, then current levels of health care resources that are devoted to the care of these patients will eventually be unable to meet the demand. This study discusses a Markov model developed to predict ESRD incidence, prevalence, and mortality to the year 2015 and incorporating expected changes in age/race distributions, diabetes prevalence, ESRD incidence, and probability of death. The model predicted that by 2015 there will be 136,166 incident ESRD patients per year (lower/upper limits 110,989 to 164,550), 712,290 prevalent patients (595,046 to 842,761), and 107,760 ESRD deaths annually (96,068 to 118,220). Incidence and prevalence counts are expected to increase by 44 and 85%, respectively, from 2000 to 2015 and incidence and prevalence rates per million population by 32 and 70%, respectively. The financial and human resources that will be needed to care for these patients in 2015 will be considerably greater than in 2005.


This article has been cited by other articles:


Home page
 CJASNHome page
L. S. Dalrymple and A. S. Go
Epidemiology of Acute Infections among Patients with Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1487 - 1493.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. D. Breyer
Stacking the Deck for Drug Discovery in Diabetic Nephropathy: In Search of an Animal Model
J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1623 - 1624.
[Full Text] [PDF]

Home page
 Arch Intern MedHome page
C.-L. Tseng, E. F. O. Kern, D. R. Miller, A. Tiwari, M. Maney, M. Rajan, and L. Pogach
Survival Benefit of Nephrologic Care in Patients With Diabetes Mellitus and Chronic Kidney Disease
Arch Intern Med, January 14, 2008; 168(1): 55 - 62.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes Spectr.Home page
R. P. Austin
An Ounce of Prevention
Diabetes Spectr, January 1, 2008; 21(1): 5 - 6.
[Full Text] [PDF]

Home page
 JAMAHome page
J. Coresh, E. Selvin, L. A. Stevens, J. Manzi, J. W. Kusek, P. Eggers, F. Van Lente, and A. S. Levey
Prevalence of Chronic Kidney Disease in the United States
JAMA, November 7, 2007; 298(17): 2038 - 2047.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
O. Khawar, K. Kalantar-Zadeh, W. K. Lo, D. Johnson, and R. Mehrotra
Is the Declining Use of Long-Term Peritoneal Dialysis Justified by Outcome Data?
Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1317 - 1328.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. Mehrotra, D. Kermah, L. Fried, K. Kalantar-Zadeh, O. Khawar, K. Norris, and A. Nissenson
Chronic Peritoneal Dialysis in the United States: Declining Utilization Despite Improving Outcomes
J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2781 - 2788.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. Himmelfarb
Chronic Kidney Disease and the Public Health: Gaps in Evidence From Interventional Trials
JAMA, June 20, 2007; 297(23): 2630 - 2633.
[Full Text] [PDF]

Home page
 Arch Intern MedHome page
E. F. Elsayed, H. Tighiouart, J. Griffith, T. Kurth, A. S. Levey, D. Salem, M. J. Sarnak, and D. E. Weiner
Cardiovascular Disease and Subsequent Kidney Disease
Arch Intern Med, June 11, 2007; 167(11): 1130 - 1136.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
K. Reynolds, D. Gu, P. Muntner, J. W. Kusek, J. Chen, X. Wu, X. Duan, C.-S. Chen, M. J. Klag, P. K. Whelton, et al.
A Population-Based, Prospective Study of Blood Pressure and Risk for End-Stage Renal Disease in China
J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1928 - 1935.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
P. H. Pun, R. W. Lehrich, S. R. Smith, and J. P. Middleton
Predictors of Survival after Cardiac Arrest in Outpatient Hemodialysis Clinics
Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 491 - 500.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Guo, P. A. Kalra, D. T. Gilbertson, J. Liu, S.-C. Chen, A. J. Collins, and R. N. Foley
Atherosclerotic Renovascular Disease in Older US Patients Starting Dialysis, 1996 to 2001
Circulation, January 2, 2007; 115(1): 50 - 58.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
S. J. L. Bakker, R. T. Gansevoort, and D. de Zeeuw
Metabolic syndrome: a fata morgana?
Nephrol. Dial. Transplant., January 1, 2007; 22(1): 15 - 20.
[Full Text] [PDF]

Home page
 CJASNHome page
C.-y. Hsu, A. S. Go, C. E. McCulloch, J. Darbinian, and C. Iribarren
Exploring Secular Trends in the Likelihood of Receiving Treatment for End-Stage Renal Disease
Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 81 - 88.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. W. Lehrich, P. H. Pun, N. D. Tanenbaum, S. R. Smith, and J. P. Middleton
Automated External Defibrillators and Survival from Cardiac Arrest in the Outpatient Hemodialysis Clinic
J. Am. Soc. Nephrol., January 1, 2007; 18(1): 312 - 320.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
T. L. Nickolas, D. J. McMahon, and E. Shane
Relationship between Moderate to Severe Kidney Disease and Hip Fracture in the United States
J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3223 - 3232.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. M. Murray, D. E. Tupper, D. S. Knopman, D. T. Gilbertson, S. L. Pederson, S. Li, G. E. Smith, A. K. Hochhalter, A. J. Collins, and R. L. Kane
Cognitive impairment in hemodialysis patients is common.
Neurology, July 25, 2006; 67(2): 216 - 223.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673